The Conversation (0)
InMed Pharmaceuticals announced that it has been included in the CSE25 Index.
InMed Pharmaceuticals (CSE:IN; OTCQB:IMLFF) announced that it has been included in the CSE25 Index.
As quoted in the press release:
InMed qualified for the index as one of the twenty-five largest companies in the CSE Composite Index.
About the CSE25 Index
On September 18, 2017, the Canadian Securities Exchange (“CSE”) announced the introduction of a new index comprised of the securities of the largest companies trading on the exchange.
Source: www.newswire.ca